Purchase Short-Term Access

Safety and Efficacy of Liposomal Amphotericin B Compared with Conventional Amphotericin B for Induction Therapy of Histoplasmosis in Patients with AIDS
Philip C. Johnson, MD; L. Joseph Wheat, MD; Gretchen A. Cloud, MS; Mitchell Goldman, MD; Dan Lancaster, MD; David M. Bamberger, MD; William G. Powderly, MD; Richard Hafner, MD; Carol A. Kauffman, MD; William E. Dismukes, MD; U.S. National Institute of Allergy and Infectious Diseases Mycoses Study Group*
Annals of Internal Medicine 2002;137:105-109. doi:10.7326/0003-4819-137-2-200207160-00008

Purchase Online access to this article for 24 hours
Buy Now

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.